A new center launched earlier this year will focus on developing a deeper understanding of the brain through the study of psychedelics. The Michigan Psychedelic Center, or M-PsyC, aims to advance multidisciplinary education, research, patient care, and community engagement related to psychedelics.
“We are in the midst of a renaissance related to psychedelic neuroscience and therapy,” said George A. Mashour, M.D., Ph.D., pictured, who is founding director of the center and chair of the Department of Anesthesiology. “Psychedelics are powerful tools to understand consciousness and also have potential to treat psychiatric disease. Our aim with the Michigan Psychedelic Center is to advance scientific understanding and clinical care through a responsible and rigorous approach.”
The center is bringing together academic faculty, researchers, health care practitioners, and students across the medical school and main campus to study psychedelics across the translational spectrum, from fundamental understanding to improved health. M-PsyC collaborators already cover a range of expertise — from neuroscience, psychiatry, pain medicine, and pharmacology, to psychology, social work, drug discovery, and the arts — with the center actively engaging units across the institution for additional partners.
“This topic is inherently multidimensional and has implications across so many different domains,” Mashour said.